Intera Atlas
Run match
Sites / Avail Clinical Research
Is this you?

Request access for Avail Clinical Research with your @availclinical.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Avail Clinical Research

Unclaimed profile

Hybrid Site Network · DeLand, FL · ~3 (DeLand, Port Orange FL; Achieve in Birmingham AL under Alcanza parent) sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 5Lift (cardio sample) 0.25Recruit soph 0.29
Quality Scorecard (1–100)
Overall63Recruit60Ops67Sponsor63Ther60

Performance (observed)

Historical trials
169
Completed
154
Terminated/Withdrawn
14
Completion rate
92%
Active now
1
Phase 2
58
Phase 3
76
Realized enrollment
264,447
First study year
2006
Years active
16
Match confidence
low
Enrollment velocity (inf)
16,528

Therapeutic

Areas
Phase I-IV multi-specialty; specialty in special patient populations
Specialties
Multiple indications (Phase I-IV)
Breadth (conditions)
126
Languages
English
States
FL, AL

Recruitment (web observed)

Trial Finder
Yes
Advertises recruitment
Yes
SEO
Good (site directory listings)
Capability notes
Active recruitment; dedicated clinical investigators

Relationships

Sponsors
Pfizer; Eli Lilly and Company; Gilead Sciences; BioDelivery Sciences International; Ferring Pharmaceuticals; Bavarian Nordic
CROs
Covance; ICON Clinical Research; Medpace, Inc.; Premier Research; Teva Branded Pharmaceutical Products R&D, Inc.
Owner / parent
Alcanza Clinical Research (acquired Accel Research Sites in July 2023); founded 1998
Funding
Private
Acquisitions
Part of Accel Research Sites
Expansion
Founded 1998, part of growing Accel network

Capacity & people

Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown (contact via web form)

Tech & DCT

CTMS
Unknown (Devana PROPEL via parent Accel)
Builds tech
Unknown
DCT / decentralized
Y - part of Accel multi-site network
Tech stack
50-bed inpatient facility; state-of-the-art research center (14,500 sq ft)
Recruiting visible
Y

Notes

Part of Accel Research Sites network (now owned by Alcanza Clinical Research). 3-site footprint (FL + AL). Strong inpatient capability (50 beds). Phase I-IV operations. Founded 1998, established track record. Network offers multi-therapeutic expertise. However, limited public visibility on tech stack or AI. Moderate Intera fit—network expansion via Alcanza acquisition signals growth momentum, but no visible innovation/recruitment tech differentiation.

Recommendation features (sample indication)

Ind fit 0.35Liftability 0.25Overall63

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.